Aptevo Therapeutics Inc. (APVO) Business News June 20, 2025, 12:55 UTC Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers Full text
There are no comments here yet...